HARBOUR BIOMED SHANGHAI CO LTD has a total of 14 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), China and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are FOOTE JEFFERSON, AARON DIAMOND AIDS RES CENTER and Black Belt Therapeutics Ltd.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | China | 3 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Singapore | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Rong Yiping | 12 |
#2 | He Yun | 12 |
#3 | Gan Xin | 9 |
#4 | Grosveld Frank | 7 |
#5 | Drabek Dubravka | 7 |
#6 | Shen Yuqiang | 7 |
#7 | Zhao Jiuqiao | 7 |
#8 | Janssens Rick | 7 |
#9 | Van Haperen Marinus (Rien) | 7 |
#10 | Liu Bin | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021063352A1 | Anti-pd-l1 antigen binding protein, and application thereof | |
WO2021032174A1 | Anti-cd47 antigen binding protein, and application thereof | |
WO2021032173A1 | Anti-cd73 antibody and application thereof | |
CN110950959A | EpCAM-targeted antibody and preparation and application thereof | |
CN110922486A | Separated protein combined with antigen PSMA and application thereof | |
KR20200101422A | Antibodies that bind to CTLA-4 and uses thereof |